MRD as an official endpoint for accelerated approval ODAC votes 12-0 great work by all congratulations!!

And the vote is in: 12 to 0 .. HUGE step for #mmsm and our patients!!! Leading the way in drug development!!

MRD ODAC for #mmsm ..”true success story for accelerated approval! 🙏 U.S. FDA Myeloma Society International Myeloma Foundation Multiple Myeloma RF HealthTree Foundation and thanks to our patients,

Teclistamab is effective in real-world patients with R/RMM, including those with prior anti-BCMA Rx exposure, albeit with slightly poorer PFS; CD8 effector T cells enhance teclistamab response Ross Firestone Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Blood Advances #mmsm #bmtsm ashpublications.org/bloodadvances/…

Multiple myeloma patients previously treated with T-cell redirection therapy have significantly low risk of developing CRS with teclistamab ⁦MSK Department of Medicine⁩ #mmsm ashpublications.org/bloodadvances/…

FDA Approves Cilta-Cel for R/R Multiple Myeloma Who Have Received at Least One Prior Line of Therapy and Are Refractory to Lenalidomide #mmsm onclive.com/view/fda-appro…

FDA Approves Ide-Cel for Triple-Class Exposed R/R Multiple Myeloma with 2+ Prior Lines of Therapy #mmsm onclive.com/view/fda-appro…

This afternoon, FDA ODAC Committee Voted in Favor of Benefit-Risk Profile of Ide-Cel in Early Relapsed/Refractory/Myeloma

#mmsm ⁦International Myeloma Foundation⁩ ⁦Multiple Myeloma RF⁩ ⁦HealthTree Foundation⁩ ⁦ASH⁩ ⁦Sylvester Comprehensive Cancer Center⁩ ⁦University of Miami⁩ onclive.com/view/fda-odac-…

FDA ODAC Committee Votes Unanimously in Favor of Benefit-Risk Profile of Cilta-Cel in Early R/R Myeloma #mmsm onclive.com/view/fda-odac-…

US Sweden Cancer Summit with signing of the US-Sweden Agreement on Cancer Research and Management by the Swedish Minister of Healthcare Acko Ankarberg Johansson and US HHS Deputy Secretary Andrea Palm

Great discussions and ideas, looking forward to more exciting collaborations!

Our editorial with Dr Paola Neri, Holly Lee⁩ out in JCO today ascopubs.org/doi/10.1200/JC… commenting on the very elegant work of ⁦Francesco Maura⁩ new artificial intelligence based individualized myeloma risk classifier.

GSK announces positive results from DREAMM-8 phase III trial for Blenrep versus standard of care combination in relapsed/refractory multiple myeloma | GSK #mmsm gsk.com/en-gb/media/pr…

Great initiative! HealthTree Foundation Announces Launch of HealthTree Research Hub in Multiple Myeloma ⁦@HealthtreeMM⁩ #mmsm prnewswire.com/news-releases/…

Don't miss your chance to join this incredible faculty lineup on March 8-11 for a comprehensive #Hematology and #MedicalOncology Update & #BoardReview Memorial Sloan Kettering Cancer Center #MSKHemOncCME

View the complete program or register at bit.ly/HemOnc2024

Join us tomorrow! Post-ASH Multiple Myeloma Highlights #mmsm vjhemonc.com/feature/post-a…

Inspired by Matthew Heineman's film #AmericanSymphony about jon batiste and suleikajaouad's leukemia journey? #JoinTheSymphony along with Barack Obama and NMDP to help patients access the life-saving blood stem cell transplants they need 👉 bit.ly/3N4HyVg

Excited to see our new paper entitled 'Genomic Classification and Individualized Prognosis in Multiple Myeloma' out on Journal of Clinical Oncology! A fantastic collaboration between Sylvester Comprehensive Cancer Center, University of Miami, Memorial Sloan Kettering Cancer Center, NYU Langone Health, Moffitt Cancer Center, Heidelberg Myeloma and many others!! #mmsm (1/x)

Congrats Princess Margaret Cancer Centre #myeloma Dr. Suzanne Trudel and Dr. Donna Reece as well as colleagues from Canadian Myeloma research group for Nature Medicine impressive results for Belantamab, pom and dex combo 85% response rate with PFS >50% at 2 years rdcu.be/dvs1o

Please spread the message and book your calendar
COMy IACH

Icelandic MGUS/SMM Screening study (a.k.a. iStopMM) steering committee in 2016 & 2023. Friendship, collaboration & innovation. The best is yet to come!

Sigurdur Kristinsson Malin Hultcrantz MD PhD Stephen Harding #mmsm #ash23 International Myeloma Foundation Multiple Myeloma RF The Leukemia & Lymphoma Society ASH @HealthtreeMM